Generex Biotechnology (GNBT) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Generex Biotechnology Short Interest DataGenerex Biotechnology (GNBT) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 60,924 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.06Short Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2022Outstanding Shares122,058,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume60,924 sharesToday's Volume Vs. Average0% Short Selling Generex Biotechnology? Sign up to receive the latest short interest report for Generex Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNBT Short Interest Over TimeGNBT Days to Cover Over TimeGNBT Percentage of Float Shorted Over Time Generex Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2022100 shares $0.06 No ChangeN/A0 $0.00 9/30/2022100 shares $0.07 No ChangeN/A0 $0.00 9/15/2022100 shares $0.08 No ChangeN/A0 $0.00 8/31/2022100 shares $0.07 No ChangeN/A0 $0.00 8/15/2022100 shares $0.10 No ChangeN/A0 $0.00 7/31/2022100 shares $0.15 No ChangeN/A0 $0.00 7/15/2022100 shares $0.49 No ChangeN/A0 $0.00 6/30/2022100 shares $0.06 No ChangeN/A0 $0.00 6/15/2022100 shares $0.06 No ChangeN/A0 $0.00 5/31/2022100 shares $0.19 No ChangeN/A0 $0.00 Get the Latest News and Ratings for GNBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Generex Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 5/15/2022100 shares $0.19 No ChangeN/A0 $0.00 4/30/2022100 shares $0.22 No ChangeN/A0 $0.00 4/15/2022100 shares $0.50 No ChangeN/A0 $0.01 3/31/2022100 shares $0.48 No ChangeN/A0 $0.00 3/15/2022100 shares $0.12 No ChangeN/A0 $0.00 2/28/2022100 shares $0.50 -99.8%N/A0 $0.01 2/15/202244,400 shares $2.93 thousand +44,300.0%N/A0.1 $0.07 1/31/2022100 shares $4.75 No ChangeN/A0 $0.05 1/15/2022100 shares $5.63 -99.5%N/A0 $0.06 12/31/202120,000 shares $1.24 thousand -43.7%N/A0 $0.06 12/15/202135,500 shares $2.84 thousand +393.1%N/A0 $0.08 11/30/20217,200 shares $860.40 -88.1%N/A0 $0.12 11/15/202160,600 shares $6.36 thousand +551.6%N/A0.1 $0.11 10/29/20219,300 shares $1.37 thousand -95.7%N/A0 $0.15 10/15/2021216,000 shares $35.99 thousand -3.0%N/A0.5 $0.17 9/30/2021222,700 shares $42.71 thousand +0.4%N/A0.5 $0.19 9/15/2021221,800 shares $39.88 thousand -3.9%N/A0.4 $0.18 8/31/2021230,900 shares $49.62 thousand +13.9%N/A0.5 $0.21 8/13/2021202,800 shares $41.57 thousand -1.6%N/A0.5 $0.21 7/30/2021206,000 shares $48.77 thousand -1.2%N/A0.5 $0.24 7/15/2021208,500 shares $49.25 thousand -5.1%N/A0.8 $0.24 6/30/2021219,600 shares $54.90 thousand -5.6%N/A0.4 $0.25 6/15/2021232,500 shares $55.29 thousand +8.9%N/A0.4 $0.24 5/28/2021213,500 shares $59.78 thousand -10.1%N/A0.6 $0.28 5/14/2021237,400 shares $65.33 thousand +13.9%N/A0.5 $0.28 4/30/2021208,500 shares $56.30 thousand -6.9%N/A0.5 $0.27 4/15/2021223,900 shares $58.77 thousand +4.9%N/A0.3 $0.26 3/31/2021213,500 shares $61.85 thousand -4.6%N/A0.4 $0.29 3/15/2021223,700 shares $85.01 thousand +1.7%N/A0.2 $0.38 2/26/2021219,900 shares $95.66 thousand -4.0%N/A0.2 $0.44Your Bank Account Is No Longer Safe (Ad)What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.Get your free guide now by clicking here >> 2/12/2021229,100 shares $98.54 thousand -36.0%N/A0.1 $0.43 1/29/2021358,200 shares $161.19 thousand -13.8%N/A0.2 $0.45 1/15/2021202,800 shares $62.20 thousand -36.7%N/A0.4 $0.31 12/31/2020204,600 shares $37.78 thousand +0.9%N/A0.2 $0.18 12/15/2020202,800 shares $44.01 thousand -36.7%N/A0.4 $0.22 11/30/2020320,600 shares $70.53 thousand +32.0%N/A0.2 $0.22 11/15/2020242,900 shares $48.31 thousand -44.9%N/A0.1 $0.20 10/30/2020440,400 shares $87.55 thousand -3.0%N/A0.6 $0.20 10/15/2020453,900 shares $110.30 thousand -15.9%N/A0.3 $0.24 9/30/2020539,600 shares $122.71 thousand -2.2%N/A0.2 $0.23 9/15/2020551,800 shares $163.83 thousand +35.0%N/A0.6 $0.30 8/31/2020408,800 shares $154.53 thousand +95.0%N/A0.3 $0.38 8/14/2020209,600 shares $88.03 thousand -7.2%N/A0.2 $0.42 7/31/2020225,900 shares $115.21 thousand -20.7%N/A0.2 $0.51 7/15/2020284,700 shares $162.28 thousand -12.3%N/A0.5 $0.57 GNBT Short Interest - Frequently Asked Questions What is Generex Biotechnology's current short interest? Short interest is the volume of Generex Biotechnology shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 100 shares of GNBT short. Learn More on Generex Biotechnology's current short interest. How does Generex Biotechnology's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Generex Biotechnology: Smart for Life, Inc. (0.01%), TC Biopharm (Holdings) Plc (176.43%), Capstone Holding Corp. (0.11%), Vincerx Pharma, Inc. (0.05%), Bon Natural Life Limited (97.97%), Universe Pharmaceuticals INC (181.67%), GlobeStar Therapeutics Corporation (0.00%), Propanc Biopharma Inc (2.11%), Neptune Wellness Solutions Inc. (1.19%), Optec International, Inc. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Corporation ($3.48 billion), Charter Communications, Inc. ($2.85 billion), Twitter, Inc. ($1.89 billion), T. Rowe Price Group, Inc. ($1.78 billion), Coinbase Global, Inc. ($1.77 billion), Pacific Gas & Electric Co. ($1.75 billion), Lucid Group, Inc. ($1.58 billion), Rivian Automotive, Inc. ($1.42 billion), Roblox Corporation ($1.39 billion), and Williams-Sonoma, Inc. ($1.33 billion). View all of the most shorted stocks. What does it mean to sell short Generex Biotechnology stock? Short selling GNBT is an investing strategy that aims to generate trading profit from Generex Biotechnology as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Generex Biotechnology? A short squeeze for Generex Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNBT, which in turn drives the price of the stock up even further. How often is Generex Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNBT, twice per month. The most recent reporting period available is October, 15 2022. More Short Interest Resources from MarketBeat Related Companies SMFL Short Squeeze TCBP Short Squeeze CAPS Short Squeeze VINC Short Squeeze BON Short Squeeze UPC Short Squeeze GSTC Short Squeeze PPCB Short Squeeze NEPTF Short Squeeze OPTI Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:GNBT) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generex Biotechnology Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Generex Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNBT Stock Alerts